Antibodies
Showing 361–375 of 397 results
-
tralokinumab
$3,603.02 – $6,303.02 -
Trastuzumab
$256.37 – $3,341.12 -
Trastuzumab (anti-HER2)
$51.17 – $1,615.82 -
trastuzumab emtansine
$3,603.02 – $6,303.02 -
tregalizumab
$3,603.02 – $6,303.02 -
Trevogrumab (anti-GDF8)
$148.37 – $5,925.02 -
U3-1784 (anti-FGFR4)
$148.37 – $3,023.87 -
Ublituximab (anti-CD20)
$80.87 – $1,606.37 -
ulenistamab
$3,603.02 – $6,303.02 -
ulocuplumab
$3,603.02 – $6,303.02 -
umizortamig
$3,603.02 – $6,303.02 -
Urelumab (anti-TNFRSF9)
$175.37 -
ustekinumab
$3,603.02 – $6,303.02 -
Utomilumab (anti-TNFRSF9)
$107.87 -
Vantictumab (anti-FZD)
$148.37 – $3,023.87